About Revance Therapeutics
Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.
|
|
|
11-50 employees
View all Revance Therapeutics employees
|
|
IT Services and IT Consulting
|
|
(510) 742-3400
|
|
Newark, CA
|
|
2002
|
Revance Therapeutics Alternatives
Frequently Asked Questions about Revance Therapeutics
Dan Browne is the CEO of Revance Therapeutics.
The decision makers in Revance Therapeutics are Dan Browne, Todd Plott, Deborah Tranowski, etc. Click to Find Revance Therapeutics decision makers emails.
Revance Therapeutics Staff Directory
Search Revance Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
